Monday, April 18, 2016

AnaptysBio Names Chief Scientific Officer

San Diego-based antibody development company AnaptysBio has named Matthew Moyle, Ph.D., as its Chief Scientific Officer, the company said this morning. Moyle was previously VP of Biotherapeutics at Boehringer Ingelheim Pharmaceuticals, and was SVP R&D and CSO at Theraclone Sciences, VP of Research at Tanox, and also served at Amgen, Corvas and Genentech.